| Role |
Name |
Disclosure |
Details |
| Author | Eve G Spratt, MD, Associate Professor of Psychiatry and Pediatrics, Pediatric Consultation Liaison Psychiatry, Medical University of South Carolina; Director, Medical University of South Carolina Children's Hospital at Charleston | Nothing to disclose | Details | | Coauthor | David R DeMaso, MD, Professor of Psychiatry (Pediatrics), Harvard Medical School; Psychiatrist-in-Chief and Chairman of Psychiatry, Children's Hospital Boston | Nothing to disclose | Details | | Medical Editor | Chet Johnson, MD, Medical Director, Child Development Unit, Department of Pediatrics, Professor, University of Kansas Medical Center | Nothing to disclose | Details | | Pharmacy Editor | Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc | Pfizer Inc Avanir Pharma | Details | | CME Editor | Carrie Sylvester, MD, MPH, Director of Education in Child and Adolescent Psychiatry, Professor, Departments of Psychiatry and Pediatrics, Northwestern University Medical School | Nothing to disclose | Details | | Chief Editor | Caroly Pataki, MD, Professor of Clinical Psychiatry, Department of Psychiatry and Biobehavioral Sciences, Division Chair of Child and Adolescent Psychiatry, Director of Training, Child and Adolescent Psychiatry Residency Program, University of Southern California Keck School of Medicine | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Eve G Spratt, Author |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Carrie Sylvester, CME Editor |
The contributor discloses no conflict of interest. |
|